Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Dermatology 2020-09, Vol.83 (3), p.955-957
Hauptverfasser:	Jimenez, Javier, Gwillim, Eran C., Kosche, Cory, Figueiredo, Anna, Rauck, Corrine, Rangel, Stephanie M., Choi, Jennifer, West, Dennis P., Nardone, Beatrice, Lacouture, Mario E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse Drug Reaction Reporting Systems - statistics & numerical data B7-H1 Antigen - antagonists & inhibitors B7-H1 Antigen - immunology Dermatology Humans Immune Checkpoint Inhibitors - adverse effects Life Sciences & Biomedicine Pharmacovigilance Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology Science & Technology Skin Diseases, Vesiculobullous - chemically induced Skin Diseases, Vesiculobullous - epidemiology Skin Diseases, Vesiculobullous - immunology United States - epidemiology United States Food and Drug Administration - statistics & numerical data
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!